With grit and integrity, we advance novel therapies for individuals with chronic neutropenic disorders

Chronic Neutropenic Disorders

Leveraging our unparalleled expertise in diseases of the immune system and CXCR4 biology, we aim to bring innovative treatments to patients with chronic neutropenic disorders.


Our lead product candidate, mavorixafor, is designed to enable mobilization of immune cells from the bone marrow into the bloodstream to improve immune system function.

© 2022 X4 Pharmaceuticals, Inc. All rights reserved. | Terms of Use | Privacy Policy

X4 Pharmaceuticals does not review or control the content on the website to which this hyperlink connects and this hyperlink does not constitute an endorsement by X4 Pharmaceuticals of the content of any non-X4 Pharmaceuticals website.